Request Deal Involvement

Sofinnova Partners led a $138m Series C funding round in Amolyt Pharma.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

LifeSci Partners

pr advisors

LifeSci Partners

Jones Day

legal advisors

Jones Day

or

Principals

TEKLA CAPITAL MANAGEMENT LLC

bidder

TEKLA CAPITAL MANAGEMENT LLC

CREDIT AGRICOLE SA

bidder

CREDIT AGRICOLE SA

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

TURENNE CAPITAL PARTENAIRES

bidder

TURENNE CAPITAL PARTENAIRES

BPIFRANCE INVESTISSEMENT

bidder

BPIFRANCE INVESTISSEMENT

MASS GENERAL BRIGHAM VENTURES

bidder

MASS GENERAL BRIGHAM VENTURES

AMOLYT PHARMA

target

AMOLYT PHARMA

SECTORAL ASSET MANAGEMENT

bidder

SECTORAL ASSET MANAGEMENT

SOFINNOVA PARTNERS

bidder

SOFINNOVA PARTNERS

INTERMEDIATE CAPITAL GROUP (ICG)

bidder

INTERMEDIATE CAPITAL GROUP (ICG)

NOVO VENTURES

bidder

NOVO VENTURES

CTI LIFE SCIENCES

bidder

CTI LIFE SCIENCES

ANDERA PARTNERS

bidder

ANDERA PARTNERS

KURMA PARTNERS

bidder

KURMA PARTNERS

EQT PARTNERS AB

bidder

EQT PARTNERS AB

PONTIFAX LIMITED

bidder

PONTIFAX LIMITED

ATEM

bidder

ATEM

NOVO HOLDINGS A/S

bidder

NOVO HOLDINGS A/S

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite